Synthetic biology for production of natural and new‐to‐nature terpenoids in photosynthetic organisms. (7th March 2016)

• Record Type: Journal Article
• Authors: Arendt, Philipp; Pollier, Jacob; Callewaert, Nico; Goossens, Alain
• Is Part Of: Plant journal. Volume 87:Number 1(2016:Jul.)
• Page Start: 16
• Page End: 37
• Publication Date: 2016-03-07
• Subjects: combinatorial biosynthesis -- heterologous biosynthesis -- metabolic engineering -- genome editing -- conjugates -- specialized metabolism; Plant molecular biology -- Periodicals; Plant cells and tissues -- Periodicals; Botany -- Periodicals; 580
• DOI: 10.1111/tpj.13138
• Languages: English
• ISSNs: 0960-7412

Abstract

Summary: With tens of thousands of characterized members, terpenoids constitute the largest class of natural compounds that are synthesized by all living organisms. Several terpenoids play primary roles in the maintenance of cell membrane fluidity, as pigments or as phytohormones, but most of them function as specialized metabolites that are involved in plant resistance to herbivores or plant–environment interactions. Terpenoids are an essential component of human nutrition, and many are economically important pharmaceuticals, aromatics and potential next‐generation biofuels. Because of the often low abundance in their natural source, as well as the demand for novel terpenoid structures with new or improved bioactivities, terpenoid biosynthesis has become a prime target for metabolic engineering and synthetic biology projects. In this review we focus on the creation of new‐to‐nature or tailor‐made plant‐derived terpenoids in photosynthetic organisms, in particular by means of combinatorial biosynthesis and the activation of silent metabolism. We reflect on the characteristics of different potential photosynthetic host organisms and recent advances in synthetic biology and discuss their utility for the (heterologous) production of (novel) terpenoids. Significance Statement: Terpenoids are the most complex group of specialized metabolites, and many are economically important pharmaceuticals, aromatics and potential next‐generation biofuels. This review highlights the utility of photosynthetic organisms as platforms for the heterologous production of novel terpenoid structures, emphasizing how combinatorial biosynthesis and the activation of silent endogenous metabolism can be exploited to produce new‐to‐nature or tailor‐made compounds.